Lupin Limited
Equibles does not estimate personal net worth.
Nilesh has spoken on 1 earnings call across 1 company, most recently for Lupin Limited on November 4, 2026. Lupin Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Yeah, so for H1, we're actually 16% ahead of the market, but definitely not where we need to be. I think the, I mean, we've seen in ResPree in particular, very slow growth.”
Lupin Limited
Transcript header (unverified)
Lupin Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Lupin Limited
